MCNA regulatory update

FDA’s Cellular, Tissue and Gene Therapies and Oncologic Drugs advisory committees will meet on Nov. 18 to discuss a BLA from Telesta for MCNA to treat high-risk non-muscle invasive bladder cancer in p...